 |
Arthritis Drugs Celebrex-Vioxx Safety in Doubt
“Arthritis drugs Vioxx, Celebrex safety in doubt”
In doubt and may not be as safe as previously thought. Research earlier this
year has shown that these drugs increased the risk of heart attacks although a
relatively low risk, over those taking a pain reliever. The FDA is debating
whether to add information about the increased risk on both drugs’ labels.
One Wall Street analyst has warned that this problem could have an adverse
effect on Merck, the drug company responsible for these drugs be placed on the
market - along with Pharmacia, which makes Celebrex, generating $2.3 billion in
12 months to March 31 of this year, Merck having sold $1.7 billion Vioxx during
the same 12 months.
Studies done last year showed that patients taking Vioxx had four times the risk
of heart attacks over patients taking Naproxen - another pain reliever. Naproxen
is also sold under the brands names of Naprosyn and Aleve. The risk of heart
attacks increases over time, at about four heart attacks per 1,000 patients.
This study was sponsored by the Merck company, which also stated that their
research does not show this problem of increased heart attacks with Vioxx.
These two drugs are among the best-sellers of prescription drugs in the world.
They cause fewer ulcers that many other drugs given for pain. Richard R. Stover,
a pharmaceutical industry analyst at Arnhold & S. Bleichroeder Inc, reported on
April 27 that he did his own analysis on what he called “disturbing data” from
Merck’s study. He stated that he was warning his clients, many of whom were
institutional investors holding stock in Merck, that they should watch the issue
carefully because it could effect the company’s stock price.
Dr. M. Michael Wolfe, chief of the gastroenterology section at the Boston
University School of Medicine and a member of the FDA advisory committee stated
that there should be a warning, after a review of the issue earlier this year,
stating that
“The marketing of these drugs is unbelievable, I’m sure there are many people
out there who are taking these drugs that should not be.”
There is a current debate going on between some doctors and Merck’s scientists
as to whether the higher risk of heart attacks is a result of Vioxx causing
damage in some patients or to an absence of the benefits that Naproxen may have
in protecting the heart, that Naproxen stops or slows the production of
thromboxane, which is thought to cause platelet in the blood to form clots,
similar to the aspirin effect.
Vioxx and Celebrex have been shown to have the same benefit in protecting the
heart.
Several doctors say they are worried about the possibility of heart attacks
because many of the arthritis patients taking the drugs are elderly and have a
higher risk of cardiovascular problems to begin with.
The current debate centers on whether the higher heart attack rate found in
patients taking Vioxx is a result of the drug’s actually causing damage in some
patients or to an absence of the heart-protecting benefits that Naproxen may
have.
“Naproxen had a similar anti-platelet effect to aspirin,” said Dr. Eve E.
Slater, senior vice president of external policy for Merck’s research labs,
“and those people had fewer heart attacks.”
Neither Vioxx nor Celebrex has been shown to have the same heart-protecting
benefit.
Slater also said that Stover’s report was flawed and biased in favor of
Pharmacia. But regulators and some doctors say they still worry that there may
be more of a problem with Vioxx.
And even if Vioxx and Celebrex do not damage the heart, the fact that they do
not have the heart-protecting benefits of aspirin reduces the ability of the
companies to market them as being significantly safer than other pain relievers.
Merck recommended last year that doctors involved in clinical trials of Vioxx
consider prescribing low doses of aspirin to patients taking Vioxx if they are
at high risk of heart attacks - although low doses of aspirin could increase the
risk of ulcers. Ulcers are the main side effect that Vioxx and Celebrex were
developed to avoid.
There have been no studies done to determine whether patients have fewer ulcers
if they take low doses of aspirin with either Vioxx or Celebrex. In February
Dr Maria Lourdes Villalba, at an FDA advisory meeting, stated that Merck had
proved Vioxx [Rofecoxib] caused fewer serious ulcers than Naproxen. However,
she also state that the potential safety advantage was offset by a higher risk
of heart problems,in her opinion. She reported that “Overall, there was no
safety superiority of Rofecoxib over Naproxen, mainly due to an excess of serious
cardiovascular events”.
Dr Villalba also stated that there had been no studies to prove Merck’s claim that
Naproxen worked like aspirin in decreasing heart attacks. The FDA expressed some
concern over the higher rate of heart attacks with Vioxx, stating that this could
be caused by the drug’s ability to produce blood clots.
“There is still a tremendous benefit with these drugs” reported Dr Eve Slater of
Merck.
About the Author
Margot B, Writer, Web Developer
Margot B has written a book and hundreds of articles, specializing in health and the environment.
mailto:margotb@wonderport.com
Web Sites by Margot B:
http://margot.bravepages.com
http://margotsnews.gossimer.net
http://websitebuilder4free.Biz-Page.com
http://www.freewebz.com/nuchatlaht
 Free Yourself of the Swelling, Stiffness and Pain, and Live Your Life 150% Better by Banishing Your Arthritis in Just One Month!
Arthritis Free For Life
|
Arthritis News
Merck Earnings Rise More Than Estimated on Job Cuts, Sales of AIDS Drugs - Fri, 30 Jul 2010 04:29:43 -0700
Merck & Co. , the second-largest U.S. drugmaker, reported quarterly profit that rose more than analyst estimates as the company cut costs and boosted sales of treatments for diabetes and AIDS. Celgene second-quarter non-GAAP total revenue increases 36% to $850 million - Thu, 29 Jul 2010 05:37:05 -0700
Celgene Corporation announced non-GAAP net income of $323.3 million, or non-GAAP diluted earnings per share of $0.69 for the quarter ended June 30, 2010. Non-GAAP net income for the second quarter of 2009 was $216.0 million or non-GAAP diluted earnings per share of $0.46. Treating Your RA: Is It Time for a Biologic? - Mon, 26 Jul 2010 11:14:32 -0700
Learn about your options for rheumatoid arthritis treatment, including what your doctor looks for, and the benefits and alternatives to a biologic.
|
|
|
|
RELATED ARTICLES
You Can Exercise With Arthritis
When a person is diagnosed with arthritis, exercise is usually the last thing on their mind. It may be difficult to walk through the grocery store, write a letter or stand on your feet. Many people assume that all exercise should be avoided. This is not true. In fact, with many forms of the disease, arthritis exercise is encouraged.
Your Joint Pain May Be Arthritis
Are you having problems with one or more joints? Are you aware of the signs which point to arthritis symptoms? If not, you should educate yourself on this disease. If diagnosed early, there is much you can do to keep arthritis symptoms at bay and to keep your joints from becoming severely damaged.
Arthritis Information Is a Click Away
Everyone who has arthritis should stay up to date with the latest arthritis information. Research on arthritis is continual. You should stay alert and watchful, as an arthritis cure will surely be found soon.
Degenerative Arthritis Is the Most Common Form of Arthritis
Degenerative arthritis, commonly known as osteoarthritis, is the result of a breakdown in the cartilage between the joints. Cartilage is necessary, as it serves as the padding between the bones. Degenerative arthritis is the most common form of arthritis. Degenerative arthritis affects upwards of 20 million people in the United States alone.
Get Arthritis Aids for Your Loved One
Individuals who suffer with arthritis can find that the simplest everyday tasks are difficult to perform. This can lead many to slump into depression as they assume they are incapable of functioning normally. These arthritis patients need to understand arthritis aids exist which can assist them in all aspects of their life. You can find many arthritis aids on the Internet.
Gout Arthritis Is Treatable
One of the most painful disorders which can affect your joints is gout arthritis. Gout arthritis has been around for eons and has been studied extensively by physicians. We now know that gout arthritis is brought on by an excessive amount of uric acid in the body. When your body has an excess of uric acid, many things can happen. Kidney stones can develop, tophi (hard nodules) may gather under the skin, and crystal deposits may also form around the joints. Gout arthritis can affect anyone. Research tells us that men are more at risk, yet women are more susceptible to gout arthritis after they go through menopause. Gout arthritis can be contributed to genetics, foods, alcohol, medication and low water consumption.
Is There an Arthritis Diet?
There are many types of arthritis, and there is typically no “diet” which an arthritis patient can be placed on. While diabetics are given much information on the foods they should eat, the foods they should avoid and portion size, arthritis patients do not have an arthritis diet to lean on.
Knee Arthritis Can Lead to Replacement Surgery
Knee arthritis is usually brought about by osteoarthritis. Osteoarthritis occurs by excessive stress on the joint. This can occur by being overweight, having an old injury, or by participating in a high impact sport or exercise program. Knee arthritis occurs as a person ages. If it occurs in a young person, they may have rheumatoid arthritis.
Many Arthritis Patients Are Choosing Glucosamine for Pain Relief
While science has yet to bring us a cure for arthritis, there are many different forms of alternative medicine which can bring arthritis pain relief. While one individual may benefit from magnet therapy and another may see relief through acupuncture, glucosamine dietary supplements are showing themselves to be the leader of the pack in regards to arthritis pain relief.
|
